Top compounds associated with response to GSDMA


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.28 4e-10
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA IU1 CTRPv2 pan-cancer AAC 0.22 5e-09
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.19 6e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-07
Download CSV